Syngene International Limited — Others, 20-08-2025: Change in Management

Syngene International has expanded its Executive Committee with five key appointments, reinforcing leadership across critical functions. These strategic additions include new heads for Strategy & Corporate Development, Chief Technology Officer, Head of Translational & Clinical Research, Head of Chemistry, and Head of Biology. The company aims to leverage their extensive experience, spanning decades in respective fields, to drive innovation, enhance operational capabilities, and positively impact future growth and scientific endeavors for shareholders.